CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise | +31,250 | $1.75 | $55K | 49,952 |
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise | +65,625 | $1.85 | $121K | 115,577 |
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise | +30,000 | $1.71 | $51K | 145,577 |
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Sale | −126,875 | $2.18 | $277K | 18,702 |
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise · Stock Option | −31,250 | 95,625 | ||
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise · Stock Option | −65,625 | 30,000 | ||
| 2016-06-01 | Dunlap Ryan Former Chief Financial Officer | Option exercise · Stock Option | −30,000 | 0 | ||
| 2015-01-16 | Dunlap Ryan VP, Chief Financial Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2014-12-31 | Dunlap Ryan VP, Chief Financial Officer | Other acquisition | +3,846 | $1.28 | $5K | 11,650 |
| 2014-06-30 | Dunlap Ryan VP, Chief Financial Officer | Other acquisition | +2,461 | $2.60 | $6K | 7,804 |
| 2013-12-31 | Dunlap Ryan Principal Accounting Officer | Other acquisition | +2,728 | $1.88 | $5K | 5,343 |
Page 1 of 1 · 11 trades